Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Prospective Real-World Outcomes After Switching to Aflibercept 8 mg in Neovascular Age-Related Macular Degeneration with High Treatment Burden

Saved in:
Bibliographic Details
Published in:Ophthalmology and Therapy
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867301677703364608
collection WordPress RSS
FRELIP Feed Integration
container_title Ophthalmology and Therapy
description
discipline_display Ophthalmology and Optometry
discipline_facet Ophthalmology and Optometry
format Online Article
RSS Article
genre Journal Article
id rss_article:60981
institution FRELIP
journal_source_facet Ophthalmology and Therapy
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Prospective Real-World Outcomes After Switching to Aflibercept 8 mg in Neovascular Age-Related Macular Degeneration with High Treatment Burden
Ophthalmology and Optometry
General
Ophthalmology and Optometry
sub_discipline_display General
sub_discipline_facet General
subject_display Ophthalmology and Optometry
General
Ophthalmology and Optometry
Ophthalmology and Optometry
General
Ophthalmology and Optometry
subject_facet Ophthalmology and Optometry
General
Ophthalmology and Optometry
title Prospective Real-World Outcomes After Switching to Aflibercept 8 mg in Neovascular Age-Related Macular Degeneration with High Treatment Burden
title_auth Prospective Real-World Outcomes After Switching to Aflibercept 8 mg in Neovascular Age-Related Macular Degeneration with High Treatment Burden
title_full Prospective Real-World Outcomes After Switching to Aflibercept 8 mg in Neovascular Age-Related Macular Degeneration with High Treatment Burden
title_fullStr Prospective Real-World Outcomes After Switching to Aflibercept 8 mg in Neovascular Age-Related Macular Degeneration with High Treatment Burden
title_full_unstemmed Prospective Real-World Outcomes After Switching to Aflibercept 8 mg in Neovascular Age-Related Macular Degeneration with High Treatment Burden
title_short Prospective Real-World Outcomes After Switching to Aflibercept 8 mg in Neovascular Age-Related Macular Degeneration with High Treatment Burden
title_sort prospective real-world outcomes after switching to aflibercept 8 mg in neovascular age-related macular degeneration with high treatment burden
topic Ophthalmology and Optometry
General
Ophthalmology and Optometry
url https://link.springer.com/article/10.1007/s40123-026-01394-1